Avidin targeting of intraperitoneal tumor xenografts

Journal of the National Cancer Institute

Volumn 90, Issue 1, 1998, Pages 25-29

  Yao, Zhengsheng ^a   Zhang, Meili ^a   Sakahara, Harumi ^a   Saga, Tsuneo ^a   Arano, Yasushi ^a   Konishi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENE THERAPY; HUMAN; LUNG CANCER; MOUSE; NUDE MOUSE; OVARY CANCER; RADIOISOTOPE DISTRIBUTION; XENOTRANSPLANTATION;

EID: 0032491807     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.1.25     Document Type: Article

References (28)

1. Lacy JH, Wieman TJ, Shively EH. Management of malignant ascites. Surg Gynecol Obstet 1984;159:397-412.
2. Esteban JM, Hyams DM, Beatty BG, Merchant B, Beatty JD. Radioimmunotherapy of human colon carcinomatosis xenograft with 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies. Cancer Res 1990;50(3 Suppl):989s-992s.
3. Muto MG, Finkler NJ, Kassis AI, Howes AE, Anderson LL, Lau CC, et al. Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125. Gynecol Oncol 1992; 45:265-72.
4. Stewart JS, Hird V, Snook D, Dhokia B, Sivolapenko G, Hooker G, et al. Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer. J Clin Oncol 1990;8:1941-50.
5. Hird V, Maraveyas A, Snook D, Dhokia B, Soutter WP, Meares C, et al. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br J Cancer 1993;68:403-6.
6. Townsend R, Stahl P. Isolation and characterization of a mannose/N-acetylglucosamine/fucose-binding protein from rat liver. Biochem J 1981; 194:209-14.
7. Hiller Y, Gershoni JM, Bayer EA, Wilchek M. Biotin binding to avidin. Oligosaccharide side chain not required for ligand association. Biochem J 1987;248:167-71.
8. Lotan R, Raz A. Lectins in cancer cells. Ann N Y Acad Sci 1988;551: 385-98.
9. Monsigny M, Roche AC, Midoux P. Endogenous lectins and drug targeting. Ann N Y Acad Sci 1988;551:399-414.
10. Gabius HJ, Engelhardt R, Cramer F. Endogenous tumor lectins: overview and perspectives. Anticancer Res 1986;6:573-8.
11. Wadhwa MS, Rice KG. Receptor mediated glycotargeting. J Drug Target 1995;3:111-27.
12. Ohannesian DW, Lotan D, Thomas P, Jessup JM, Fukuda M, Gabius HJ, et al. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res 1995; 55:2191-9.
13. Pardridge WM, Kang YS, Yang J, Buciak JL. Enhanced cellular uptake and in vivo biodistribution of a monoclonal antibody following cationization. J Pharm Sci 1995;84:943-8.
14. Kumagai AK, Eisenberg JB, Pardridge WM. Absorptive-mediated endocytosis of cationized albumin and a β-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem 1987;262:15214-9.
15. Triguero D, Buciak JB, Yang J, Pardridge WM. Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci U S A 1989;86:4761-5.
16. Triguero D, Buciak JL, Pardridge WM. Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate. J Pharmacol Exp Ther 1991;258: 186-92.
17. Pardridge WM, Bickel U, Buciak J, Yang J, Diagne A. Aepinus C. Cationization of a monoclonal antibody to the human immunodeficiency virus REV protein enhances cellular uptake but does not impair antigen binding of the antibody. Immunol Lett 1994;42:191-5.
18. Rosebrough SF, Hartley DF. Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis. J Nucl Med 1996;37:1380-4.
19. Rosebrough SF. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin. Nucl Med Biol 1993;20:663-8.
20. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs (NJ): Prentice-Hall, 1984.
21. Schechter B, Silberman R, Arnon R, Wilchek M. Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin. Eur J Biochem 1990;189: 327-31.
22. Kobayashi H, Sakahara H, Hosono M, Yao Z, Toyama S, Endo K, et al. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor. J Nucl Med 1994;35:1677-84.
23. Yao Z, Zhang M, Kobayashi H, Sakahara H, Nakada H, Yamashina I, et al. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase. J Nucl Med 1995;36:837-41.
24. Kobayashi H, Sakahara H, Endo K, Hosono M, Yao Z, Toyama S, et al. Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody. Jpn J Cancer Res 1995;86:310-4.
25. Mattes MJ. Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications. J Natl Cancer Inst 1987;79:855-63.
26. Jeong JM, Kinuya S, Paik CH, Saga T, Sood VK, Carrasquillo JA, et al. Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pI on biodistribution. Nucl Med Biol 1994;21:935-40.
27. Zhang M, Yao Z, Sakahara H, Saga T, Nakamoto Y, Sato N, et al. Effect of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multistep targeting. Nucl Med Biol. In press.
28. Trail PA, Willner D, Lasch SJ, Henderson AJ, Hofstead S, Casazza AM, et al. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates [published erratum appears in Science 1994;263:1076]. Science 1993;261:212-5.